


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.90%
+9.19%
+2.92%
+2.30%
-1.97%
LLY
Eli Lilly and
$1039.51
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
LLY Price Performance
$1079.75 (-3.73%)
$862.86 (+20.47%)
$742.91 (+39.92%)
$871.86 (+19.23%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
LLY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level

Average key support and resistance price levels
NVO
62.89
-1.70%
PFE
26.50
+2.40%
MRK
107.92
+0.51%
NVS
152.22
+2.08%
VTYX
13.99
0.00%
LLY
Eli Lilly and
1039.51
-2.14%
MRK
Merck Company
107.92
+0.51%
EXC
Exelon
44.83
+0.63%
MGY
Magnolia Oil Gas
24.70
+1.27%
INBS
Intelligent Bio Solutions
8.86
-2.53%
What is LLY current stock price?
What are LLY stock strengths?
What is LLY Risk Level?
What is LLY market cap and volume?
What is LLY current Stock IQ?
Should I buy LLY stock right now?
Is LLY a Strong Buy right now?
What does a 'Strong Buy' rating mean for LLY?
What does a 'Strong Sell' rating mean for LLY?
What factors influence LLY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.90%
+9.19%
+2.92%
+2.30%
-1.97%
LLY
Eli Lilly and
Current Price
$1039.51
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Linked to LLY
NVO
62.89
-1.70%
PFE
26.50
+2.40%
MRK
107.92
+0.51%
NVS
152.22
+2.08%
VTYX
13.99
0.00%
Recently Viewed
LLY
Eli Lilly and
1039.51
-2.14%
MRK
Merck Company
107.92
+0.51%
EXC
Exelon
44.83
+0.63%
MGY
Magnolia Oil Gas
24.70
+1.27%
INBS
Intelligent Bio Solutions
8.86
-2.53%

LLY Price Performance
$1079.75 (-3.73%)
$862.86 (+20.47%)
$742.91 (+39.92%)
$871.86 (+19.23%)
LLY Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
LLY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 09, 2026
Initiate
Buy
UBS
Dec 22, 2025
Reiterate
Buy
BofA
Dec 18, 2025
Upgrade
Buy
Goldman Sachs
Dec 16, 2025
Reiterate
Buy
B of A Securities
Dec 08, 2025
Reiterate
Buy
Guggenheim
LLY Stock IQ
LLY Latest Analysis
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It. Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So it is worth exploring what lies ahead for the stock.
Tue Jan 27, 2026
Up 36% Is Eli Lilly Still a Buy?. Key PointsEli Lilly is at the forefront of both diabetes and obesity medications.
Tue Jan 27, 2026
Eli Lilly (LLY) Oncology Pipeline and $1B Nvidia (NVDA) AI Partnership Signal Strong 2026 Growth. Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20 Eli Lilly received FDA Breakthrough Therapy designation for sofetabart mipitecan. This status applies to the treatment of adults with platinum-resistant ovarian fallopian tube or primary peritoneal cancer whose disease has progressed despite prior therapies. [….]
Tue Jan 27, 2026
My Top AI Healthcare Stock to Buy and Hold for 20 Years. Key PointsEli Lilly has made several moves to boost its artificial intelligence (AI) capacity.
Mon Jan 26, 2026
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know. Eli Lilly (LLY) closed at $1 in the latest trading session marking a -2.12% move from the prior day.
Fri Jan 23, 2026
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?. Key PointsEli Lilly is at the forefront of the GLP-1 weight loss drug market.
Fri Jan 23, 2026
Heres How Eli Lillys Oncology Drugs Are Poised Ahead of Q4 Earnings. LLYs oncology drugs led by Verzenio and new launches are set to support upcoming Q4 results as investor focus broadens beyond GLP-1s.
Fri Jan 23, 2026
Eli Lilly Soared by 39% in 2025 but Heres Another Healthcare Stock to Buy in 2026. Key PointsEli Lilly has skyrocketed due to its strength in the high-growth obesity drug market.
Fri Jan 23, 2026
Novo Nordisk: How Inspiring New CEO Will Take Fight To Key Rival Eli Lilly In 2026.
Wed Jan 21, 2026
Eli Lilly: Buy Ahead Of Its Earnings Day (Preview).
Wed Jan 21, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.